This compound is a pharmaceutical intermediate used in the manufacturing process of baricitinib. It is a research-stage chemical reagent characterized by a complex heterocyclic structure.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
2-(1-(Ethylsulfonyl)-3-(4-(7-((2-(trimethylsilyl)ethoxy)methyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile
pharmaceutical intermediate
4-(Dimethylamino)but-2-ynoic acid hydrochloride
pharmaceutical intermediate
6-Chloroquinoline-3-carboxylic acid
pharmaceutical intermediate
(2R)-2-(Aminomethyl)-1-pyrrolidinecarboxylic acid phenylmethyl ester
pharmaceutical intermediate
Triethyl butane-1,2,4-tricarboxylate
pharmaceutical intermediate
Tert-butyl 4-(1-(3-(cyanomethyl)-1-(ethylsulfonyl)azetidin-3-yl)-1H-pyrazol-4-yl)-7H-pyrrolo[2,3-d]pyrimidine-7-carboxylate
research compound
Baricitinib
pharmaceutical raw material
Phosphoric acid--{1-(ethanesulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]azetidin-3-yl}acetonitrile (1/1)
pharmaceutical raw material
[4-[1-[3-(cyanomethyl)-1-ethylsulfonylazetidin-3-yl]pyrazol-4-yl]pyrrolo[2,3-d]pyrimidin-7-yl]methyl 2,2-dimethylpropanoate
WENIISNHSRPUOW-UHFFFAOYSA-N
CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CN(C4=NC=N3)COC(=O)C(C)(C)C
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.